Garcia Maria D, Hur Minjun, Chen John J, Bhatti M Tariq
Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Am J Ophthalmol Case Rep. 2020 Jan 25;17:100606. doi: 10.1016/j.ajoc.2020.100606. eCollection 2020 Mar.
We detail a case of cobalt toxicity with visual and systemic complications, review the pathogenic process for the optic neuropathy and retinopathy, and discuss the controversy of metallic hip prosthesis.
A 59-year-old female with a history of multiple left hip arthroplasties presented to our clinic with bilateral visual loss. The year prior, she had failure of the hip implant necessitating revision surgery with placement of a chrome-cobalt head. A few months after surgery, she began experiencing blurred and "white, spotty" vision in both eyes in addition to hypothyroidism, cardiomyopathy and neuropathy. The possibility of the patient's symptoms being due to cobalt toxicity from her hip prosthesis was proposed and she was found to have a serum cobalt level >1000 μg/L (normal 0-0.9 ng/mL). Visual acuity was 20/600 in the right and 20/800 in the left eye. There was bilateral temporal optic disc pallor. Goldmann visual field testing demonstrated bilateral central scotomas, optical coherence tomography (OCT) showed severe ganglion cell layer-inner plexiform layer (GCLIPL) thinning and multifocal electroretinography (mfERG) demonstrated decreased amplitudes in both eyes. She underwent a total hip revision arthroplasty with extensive debridement of "black sludge" found within a pseudocapsule. Four days after surgery, cobalt serum levels had significantly decreased to 378 ng/mL. One month after surgery, she had significant improvement in visual acuity (20/150 right eye, 20/250 left eye), Goldmann visual field testing, and mfERG. OCT showed retinal nerve fiber thinning and persistent GCLIPL thinning in both eyes.
Excessive cobalt levels can result in systemic toxicity leading to visual changes, peripheral neuropathy, hearing loss, cognitive deficits, cardiomyopathy and hypothyroidism. In recent years it has become apparent that cobalt toxicity can be associated with metal-on-metal total hip arthroplasty, or the grinding effects of retained ceramic particles from a fractured ceramic head on a cobalt-chromium femoral head prosthesis.
我们详细介绍一例伴有视觉及全身并发症的钴中毒病例,回顾视神经病变和视网膜病变的致病过程,并讨论金属髋关节假体的争议问题。
一名有多次左髋关节置换病史的59岁女性因双眼视力丧失就诊于我们的诊所。前一年,她的髋关节植入物出现故障,需要进行翻修手术并植入铬钴合金股骨头。术后几个月,除甲状腺功能减退、心肌病和神经病变外,她开始出现双眼视力模糊以及“白色斑点状”视力。有人提出患者的症状可能是由于髋关节假体中的钴中毒所致,结果发现她的血清钴水平>1000μg/L(正常范围0 - 0.9ng/mL)。右眼视力为20/600,左眼视力为20/800。双侧颞侧视盘苍白。Goldmann视野检查显示双侧中心暗点,光学相干断层扫描(OCT)显示严重的神经节细胞层 - 内网状层(GCLIPL)变薄,多焦视网膜电图(mfERG)显示双眼振幅降低。她接受了全髋关节翻修置换术,并对在假包膜内发现的“黑色淤渣”进行了广泛清创。术后四天,血清钴水平显著降至378ng/mL。术后一个月,她的视力(右眼20/150,左眼20/250)、Goldmann视野检查和mfERG有了显著改善。OCT显示双眼视网膜神经纤维变薄以及GCLIPL持续变薄。
钴水平过高可导致全身中毒,引发视觉改变、周围神经病变、听力丧失、认知缺陷、心肌病和甲状腺功能减退。近年来,很明显钴中毒可能与金属对金属全髋关节置换术有关,或者与骨折陶瓷头中残留的陶瓷颗粒对钴铬合金股骨头假体的研磨作用有关。